Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease.

@article{Cazzola2006SingleIB,
  title={Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease.},
  author={Mario Cazzola},
  journal={Pulmonary pharmacology & therapeutics},
  year={2006},
  volume={19 2},
  pages={79-89}
}
  • Mario Cazzola
  • Published 2006 in Pulmonary pharmacology & therapeutics
Inhaled bronchodilators, particularly short-acting inhaled beta(2)-agonists, and systemic glucocorticosteroids are effective treatments for acute exacerbations of chronic obstructive pulmonary disease (COPD). However, in the treatment of these episodes there may be some advantages to the longer-acting agents in that there will be prolonged bronchodilation. Moreover, high doses of systemic glucocorticosteroids are associated with a significant risk of side effects. In the last few years… CONTINUE READING